533 related articles for article (PubMed ID: 17465946)
1. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
2. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
3. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
[TBL] [Abstract][Full Text] [Related]
4. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
5. Blast counts in blood progenitor cell (BPC) correlate with CD34+ cells and CFU-GM and are useful predictor of haemopoietic recovery after autologous BPC transplantation collections.
Mijovic A; Fishlock K; Pagliuca A; Mufti GJ
Bone Marrow Transplant; 1998 May; 21(9):869-72. PubMed ID: 9613777
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
[TBL] [Abstract][Full Text] [Related]
8. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
[TBL] [Abstract][Full Text] [Related]
9. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests.
Zimmerman TM; Lee WJ; Bender JG; Mick R; Williams SF
Bone Marrow Transplant; 1995 Mar; 15(3):439-44. PubMed ID: 7541269
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR
Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
12. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
[TBL] [Abstract][Full Text] [Related]
13. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
Han XH; Shi YK; He XH; Yang JL; Liu P
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
[TBL] [Abstract][Full Text] [Related]
14. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients.
Yoo KH; Lee SH; Kim HJ; Sung KW; Jung HL; Cho EJ; Park HK; Kim HA; Koo HH
Bone Marrow Transplant; 2007 May; 39(9):515-21. PubMed ID: 17334379
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
16. Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue.
Millar BC; Millar JL; Bell JB; Raje N; Milan S; Mehta J; Singhal S; Middleton GW; Sheperd V; Catovsky D; Powles RL
Bone Marrow Transplant; 1996 Nov; 18(5):871-8. PubMed ID: 8932839
[TBL] [Abstract][Full Text] [Related]
17. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment.
Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE
Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
Watanabe T; Dave B; Heimann DG; Jackson JD; Kessinger A; Talmadge JE
Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
Lowenthal RM; Fabères C; Marit G; Boiron JM; Cony-Makhoul P; Pigneux A; Agape P; Vezon G; Bouzgarou R; Dazey B; Fizet D; Bernard P; Lacombe F; Reiffers J
Bone Marrow Transplant; 1998 Oct; 22(8):763-70. PubMed ID: 9827973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
